Back to Search
Start Over
Local Treatment of Meniscal Lesions with Vascular Endothelial Growth Factor
- Source :
- The Journal of Bone and Joint Surgery-American Volume. 92:2682-2691
- Publication Year :
- 2010
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2010.
-
Abstract
- Background: The healing potential in the avascular regions of the meniscus is very limited, and improving the vascularity might be a reasonable way to improve healing. Vascular endothelial growth factor (VEGF) is one of the most potent proangiogenetic factors. We hypothesized that the local application of VEGF165 would (1) improve the healing of a lesion in the avascular region of the meniscus, (2) induce angiogenesis in both the avascular and vascular regions, and (3) increase the amounts of VEGF mRNA and VEGF. Methods: In eighteen sheep, the medial menisci were cut longitudinally in the avascular region and were sutured. Three groups were established depending on the suture material: (1) uncoated Ethibond, (2) Ethibond coated with VEGF165 and its carrier Poly(D,L–Lactide) (PDLLA), and (3) Ethibond coated with PDLLA. The contralateral medial menisci served as a control group. Each of the three suture type groups included six animals. After eight weeks, the sheep were killed, and the menisci were examined macroscopically. Immunohistochemistry of Factor VIII and VEGF and real-time reverse-transcription polymerase chain reaction (RT-PCR) of VEGF mRNA were performed. Additionally, the VEGF release kinetics from the VEGF/PDLLA-coated suture were evaluated in vitro. Results: In this model, VEGF did not improve meniscal healing. It did not increase angiogenesis in the avascular or vascular region, the VEGF concentration, or the amount of VEGF mRNA. VEGF release from the coated suture peaked on Day 3 and was nearly zero on Day 9. Conclusions: The local application of VEGF165 as eluted from suture did not increase meniscal angiogenesis or improve meniscal healing. In addition, there was no effect on the amount of VEGF mRNA and VEGF. The VEGF carrier (PDLLA) may have been inadequate because of the short duration of VEGF supply. Clinical Relevance: This study shows that the application of VEGF at one time point might not be a solution to improve meniscal healing.
- Subjects :
- Pathology
medicine.medical_specialty
Angiogenesis
Injections, Intralesional
Meniscus (anatomy)
Menisci, Tibial
Statistics, Nonparametric
Lesion
Random Allocation
chemistry.chemical_compound
Vascularity
Suture (anatomy)
Reference Values
Biopsy
medicine
Animals
Orthopedics and Sports Medicine
RNA, Messenger
Wound Healing
Factor VIII
Sheep
medicine.diagnostic_test
Reverse Transcriptase Polymerase Chain Reaction
Vascular Endothelial Growth Factors
business.industry
Biopsy, Needle
Suture Techniques
General Medicine
Immunohistochemistry
Vascular endothelial growth factor
Disease Models, Animal
medicine.anatomical_structure
chemistry
Female
Surgery
medicine.symptom
business
Biomarkers
Subjects
Details
- ISSN :
- 00219355
- Volume :
- 92
- Database :
- OpenAIRE
- Journal :
- The Journal of Bone and Joint Surgery-American Volume
- Accession number :
- edsair.doi.dedup.....761686d155b247f215792409b4683f8c
- Full Text :
- https://doi.org/10.2106/jbjs.i.01481